 |
tadekinig alfa |
|---|---|
| Trade Name | |
| Orphan Indication | Still’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-03 00:00:00 |
| Sponsor | AB2 Bio Ltd;EPFL Innovation Park, Building B;Lausanne |
| |
tadekinig alfa |
|---|---|
| Trade Name | |
| Orphan Indication | Still’s disease |
| USA Market Approval | USA |
| USA Designation Date | 2017-07-03 00:00:00 |
| Sponsor | AB2 Bio Ltd;EPFL Innovation Park, Building B;Lausanne |